Insider Selling: Heartflow (NASDAQ:HTFL) CFO Sells $1,487,482.84 in Stock

16 Sep 2026, 01:09 by Sarita Garza · The Markets Daily

Heartflow, Inc. (NASDAQ:HTFL – Get Free Report) CFO Vikram Verghese sold 29,714 shares of Heartflow stock in a transaction dated Friday, September 11th. The stock was sold at an average price of $50.06, for a total value of $1,487,482.84. Following the completion of the transaction, the chief financial officer owned 184,789 shares of the company’s stock, valued at $9,250,537.34. This trade represents a 13.85% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Vikram Verghese also recently made the following trade(s):

On Tuesday, September 15th, Vikram Verghese sold 668 shares of Heartflow stock. The stock was sold at an average price of $50.01, for a total transaction of $33,406.68.
On Monday, September 14th, Vikram Verghese sold 4,593 shares of Heartflow stock. The stock was sold at an average price of $50.24, for a total value of $230,752.32.
On Tuesday, September 8th, Vikram Verghese sold 6,640 shares of Heartflow stock. The shares were sold at an average price of $50.03, for a total value of $332,199.20.
On Thursday, September 3rd, Vikram Verghese sold 27,540 shares of Heartflow stock. The stock was sold at an average price of $49.69, for a total value of $1,368,462.60.
On Wednesday, September 2nd, Vikram Verghese sold 5,876 shares of Heartflow stock. The stock was sold at an average price of $50.60, for a total transaction of $297,325.60.

Heartflow Stock Down 2.4%

Shares of HTFL stock traded down $1.21 during trading hours on Tuesday, reaching $48.33. The stock had a trading volume of 2,031,448 shares, compared to its average volume of 1,972,264. The firm has a 50-day simple moving average of $36.39 and a 200-day simple moving average of $31.21. Heartflow, Inc. has a twelve month low of $20.13 and a twelve month high of $51.78.

Heartflow (NASDAQ:HTFL – Get Free Report) last announced its quarterly earnings results on Thursday, August 13th. The company reported ($0.07) EPS for the quarter, beating the consensus estimate of ($0.22) by $0.15. The company had revenue of $64.08 million for the quarter. Heartflow had a negative net margin of 55.82% and a negative return on equity of 23.52%. The business’s quarterly revenue was up 47.7% compared to the same quarter last year. As a group, sell-side analysts predict that Heartflow, Inc. will post -0.75 EPS for the current year.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on HTFL shares. Freedom Capital upgraded shares of Heartflow to a “strong-buy” rating in a research note on Tuesday, June 30th. Piper Sandler reissued an “overweight” rating and set a $45.00 target price (up from $38.00) on shares of Heartflow in a research note on Friday, August 14th. Wells Fargo & Company boosted their price target on shares of Heartflow from $37.00 to $39.00 and gave the stock an “overweight” rating in a research report on Friday, August 14th. JPMorgan Chase & Co. upped their price target on shares of Heartflow from $35.00 to $45.00 and gave the stock an “overweight” rating in a research note on Friday, August 14th. Finally, Morgan Stanley raised their price objective on shares of Heartflow from $35.00 to $40.00 and gave the company an “equal weight” rating in a research note on Friday, August 14th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $44.88.

View Our Latest Research Report on Heartflow

Institutional Investors Weigh In On Heartflow

Several hedge funds and other institutional investors have recently bought and sold shares of HTFL. Integrated Wealth Concepts LLC bought a new position in shares of Heartflow during the 2nd quarter valued at about $53,000. Essential Partners LLC bought a new stake in shares of Heartflow in the 1st quarter worth approximately $57,000. Caitong International Asset Management Co. Ltd bought a new stake in shares of Heartflow in the 4th quarter worth approximately $72,000. Strs Ohio lifted its stake in Heartflow by 35.3% during the first quarter. Strs Ohio now owns 4,600 shares of the company’s stock valued at $112,000 after purchasing an additional 1,200 shares during the last quarter. Finally, Bessemer Group Inc. bought a new stake in Heartflow during the first quarter worth approximately $126,000.

Key Headlines Impacting Heartflow

Here are the key news stories impacting Heartflow this week:

Positive Sentiment: Heartflow’s latest quarterly results showed strong operating momentum: revenue rose 47.7% year over year to $64.08 million, while its $0.07-per-share loss was narrower than analysts expected. Heartflow stock and earnings information
Positive Sentiment: Several institutions recently initiated or increased positions, including Squarepoint Ops, which lifted its stake by 72%, providing a potential source of buying support.
Positive Sentiment: Analyst sentiment remains broadly favorable, with a consensus “Moderate Buy” rating. UBS set a $55 price target, above the recent trading range, while other firms maintained Buy or Overweight ratings.
Neutral Sentiment: The CFO’s sales were disclosed as part of a planned trading program, reducing the likelihood that the transactions represent a new negative view of Heartflow’s business. After selling 35,?—actually 35,? shares across September 11–15, CFO Vikram Verghese still owned roughly 179,528 shares.
Negative Sentiment: CFO Vikram Verghese sold a combined 34,975 shares for approximately $1.75 million at prices near $50 per share, reducing his direct ownership by roughly 16.7% over the reported transactions. CFO SEC filing
Negative Sentiment: CEO John Farquhar also sold 38,900 shares for approximately $1.82 million on September 10–11 and has reported multiple sales since June. The repeated selling by senior executives, particularly after the stock approached its 52-week high, is likely contributing to short-term pressure. HeartFlow CEO share sale

About Heartflow

(Get Free Report)

Heartflow, Inc is a medical technology company that develops artificial intelligence and imaging solutions for the diagnosis and management of coronary artery disease. Its platform analyzes data from coronary computed tomography angiography (CCTA) scans to create personalized, three-dimensional models of a patient’s coronary arteries.